1. Araki, K., M. Araki, J. Miyazaki, and P. Vassalli. 1995. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci U S A 92:160-164.
2. Askew, G. R., T. Doetschman, and J. B. Lingrel. 1993. Site-directed point mutations in embryonic stem cells: a gene-targeting tag-and-exchange strategy. Mol. Cell. Biol. 13:4115-4124.
3. Avner, P., and E. Heard. 2001. X-chromosome inactivation: counting, choice and initiation. Nat Rev Genet 2:59-67.
4. Barinaga, M. 1994. Knockout Mice: Round Two. Science 265:26-28.
5. Betz, U. A. K., C. A. J. Voßhenrich, K. Rajewsky, and W. Müller. 1996. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination. Current Biology 6:1307-1316.
6. Bradley, A., and P. Liu. 1996. Target practice in transgenics. Nat. Genet. 14:121-123.
7. Brandon, E. P., R. L. Idzerda, and G. S. McKnight. 1995. Targeting the mouse genome: a compendium of knockouts (Part I). Curr Biol 5:625-634.
8. Brandon, E. P., R. L. Idzerda, and G. S. McKnight. 1995. Targeting the mouse genome: a compendium of knockouts (Part III). Curr Biol 5:873-881.
9. Braun, T., and H. H. Arnold. 1995. Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. EMBO J. 14:1176-1186.
10. Brinster, R. l., H. Y. Chen, M. E. Trumbauer, M. K. Yagle, and R. D. Palmiter. 1985. Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc. Natl. Acad. Sci. USA 82:4438-4442.
11. Brockdorff, N., A. Ashworth, G. F. Kay, V. M. McCabe, D. P. Norris, P. J. Cooper, S. Swift, and S. Rastan. 1992. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 71:515-526.
12. Brown, C. J., B. D. Hendrich, J. L. Rupert, R. G. Lafreniere, Y. Xing, J. Lawrence, and H. F. Willard. 1992. The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 71:527-542.
13. Brown, C. J., and H. F. Willard. 1994. The human X-inactivation centre is not required for maintenance of X- chromosome inactivation. Nature 368:154-156.
14. Brown, P. O., and L. Hartwell. 1998. Genomics and human disease--variations on variation. Nat. Genet. 18:91-93.
15. Chen, J., R. Lansford, V. Stewart, F. Young, and F. W. Alt. 1993. RAG-2-deficient blastocyst complementation: An assay of gene function in lymphocyte development. Proc. Natl. Acad. Sci. USA 90:4528-4532.
16. Church, D. M., L. T. Banks, A. C. Rogers, S. L. Graw, D. E. Housman, J. F. Gusella, and A. J. Buckler. 1993. Identification of human chromosome 9 specific genes using exon amplification. Hum Mol Genet 2:1915-1920.
17. Church, D. M., C. J. Stotler, J. L. Rutter, J. R. Murrell, J. A. Trofatter, and A. J. Buckler. 1994. Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nat. Genet. 6:98-105.
18. Clarke, H., S. Varmuza, V. Prideaux, and J. Rossant. 1988. The developmental potential of parthenogenetically derived cells in chimeric mouse embryos: implications for action of imprinted genes. Development 104:175-182.
19. Collins, F. S. 1992. Postional cloning: Let's not call it reverse anymore. Nat. Genet. 1:3-6.
20. Collins, F. S., M. S. Guyer, and A. Charkravarti. 1997. Variations on a theme: cataloging human DNA sequence variation. Science 278:1580-1581.
21. Copeland, N. G., and N. A. Jenkins. 1991. Development and applications of a molecular genetic linkage map of the mouse genome. Trends Genet. 7:113-118.
22. Copeland, N. G., N. A. Jenkins, D. J. Gilbert, J. T. Eppig, L. J. Maltais, J. C. Miller, W. F. Dietrich, A. Weaver, S. E. Lincoln, R. G. Steen, and et al. 1993. A genetic linkage map of the mouse: current applications and future prospects [see comments]. Science 262:57-66.
23. Copp, A. J. 1995. Death before birth: clues from gene knockouts and mutations. Trends Genet. 11:87-93.
24. Crawley, J. N. 2000. What's Wrong With My Mouse, 1 ed. Wiley-Liss, New York.
25. Cronin, C. A., W. Gluba, and H. Scrable. 2001. The lac operator-repressor system is functional in the mouse. Genes & Dev. 15:1506-1517.
26. Davies, K. 1994. Damage report for BRCA1. Nature 372:574.
27. Detloff, P. J., J. Lewis, S. W. John, W. R. Shehee, R. Langenbach, N. Maeda, and O. Smithies. 1994. Deletion and replacement of the mouse adult beta-globin genes by a "plug and socket" repeated targeting strategy. Mol. Cell. Biol. 14:6936-6943.
28. Dietrich, S., F. Abou-Rebyeh, H. Brohmann, F. Bladt, E. Sonnenberg-Riethmacher, T. Yamaai, A. Lumsden, B. Brand-Saberi, and C. Birchmeier. 1999. The role of SF/HGF and c-Met in the development of skeletal muscle. Development 126:1621-1629.
29. Ding, Q., J. J. Lewis, K. M. Strum, E. Dimayuga, A. J. Bruce-Keller, J. C. Dunn, and J. N. Keller. 2002. Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival. J. Biol. Chem. 277:13935-13942.
30. Doetschman, T., R. G. Gregg, N. Maeda, M. L. Hooper, D. W. Melton, S. Thompson, and O. Smithies. 1987. Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330:576-578.
31. Doetschman, T., N. Maeda, and O. Smithies. 1988. Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc Natl Acad Sci U S A 85:8583-8587.
32. Doetschmann, T. C., H. Eistetter, M. Katz, W. Scmidt, and R. Kemler. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islets and myocardium. J. Embryol. Exp. Morph. 87:27-45.
33. Donehower, L. A., M. Harvey, H. Vogel, M. J. McArthur, C. A. Montgomery, Jr., S. H. Park, T. Thompson, R. J. Ford, and A. Bradley. 1995. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog 14:16-22.
34. Eggan, K., H. Akutsu, K. Hochedlinger, W. Rideout, R. Yanagimachi, and R. Jaenisch. 2000. X-Chromosome inactivation in cloned mouse embryos. Science 290:1578-1581.
35. Fiering, S., E. Epner, K. Robinson, Y. Zhuang, A. Telling, M. Hu, D. I. Martin, T. Enver, T. J. Ley, and M. Groudine. 1995. Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes & Dev. 9:2203-2213.
36. Fiering, S., C. G. Kim, E. M. Epner, and M. Groudine. 1993. An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the beta-globin locus control region. Proc Natl Acad Sci U S A 90:8469-8473.
37. Friedrich, G., and P. Soriano. 1991. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes & Dev. 5:1513-1523.
38. Fu, Y. H., D. P. Kuhl, A. Pizzuti, M. Pieretti, J. S. Sutcliffe, S. Richards, A. J. Verkerk, J. J. Holden, R. G. Fenwick, Jr., S. T. Warren, and et al. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058.
39. Futreal, P. A., Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L. M. Bennett, A. Haugen-Strano, J. Swensen, Y. Miki, and et al. 1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122.
40. Goldhamer, D. J., A. Faerman, M. Shani, and C. P. Emerson, Jr. 1992. Regulatory elements that control the lineage-specific expression of myoD. Science 256:538-542.
41. Gossler, A., A. L. Joyner, J. Rossant, and W. C. Skarnes. 1989. Mouse embryonic stem cells and reporter constructs to detect developmentally regulated genes. Science 244:463-465.
42. Goto, Y., and N. Takagi. 1998. Tetraploid embryos rescue embryonic lethality caused by an additional maternally inherited X chromosome in the mouse. Development 125:3353-3363.
43. Gu, H. 1994. Gene targeting and its application to the study of B-cell development. Curr Opin Immunol 6:308-312.
44. Gu, H., J. D. Marth, P. C. Orban, H. Mossmann, and K. Rajewsky. 1994. Deletion of a DNA polymerase ß gene segment in T cells using cell type-specific gene targeting. Science 265:103-106.
45. Guillemot, F., T. Caspary, S. M. Tilghman, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, D. J. Anderson, A. L. Joyner, J. Rossant, and A. Nagy. 1995. Genomic imprinting of Mash2, a mouse gene required for trophoblast development. Nat. Genet. 9:235-242.
46. Guillemot, F., A. Nagy, A. Auerbach, J. Rossant, and A. L. Joyner. 1994. Essential role of Mash-2 in extraembryonic development. Nature 371:333-336.
47. Hanahan, D. 1989. Transgenic mice as probes into complex systems. Science 246:1265-1274.
48. Hanks, M., W. Wurst, L. Anson-Cartwright, A. B. Auerbach, and A. L. Joyner. 1995. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 269:679-682.
49. Hardouin, N., and A. Nagy. 2000. Gene-trap-based target site for cre-mediated transgenic insertion. Genesis 26:245-252.
50. Harshman, K., R. Bell, J. Rosenthal, H. Katcher, Y. Miki, J. Swenson, Z. Gholami, C. Frye, W. Ding, P. Dayananth, and et al. 1995. Comparison of the positional cloning methods used to isolate the BRCA1 gene. Hum Mol Genet 4:1259-1266.
51. Harvey, M., M. J. McArthur, C. A. Montgomery, Jr., A. Bradley, and L. A. Donehower. 1993. Genetic background alters the spectrum of tumors that develop in p53- deficient mice. Faseb J 7:938-943.
52. Hasty, P., A. Bradley, J. H. Morris, D. G. Edmondson, J. M. Venuti, E. N. Olson, and W. H. Klein. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364:501-506.
53. Hochedlinger, K., and R. Jaenisch. 2002. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415:1035-1038.
54. Hoffman, E. P., R. H. Brown, Jr., and L. M. Kunkel. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928.
55. Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the Mouse Embryo; A Laboratory Manual, Second Edition ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
56. Humpherys, D., K. Eggan, H. Akutsu, K. Hochedlinger, W. M. Rideout, 3rd, D. Biniszkiewicz, R. Yanagimachi, and R. Jaenisch. 2001. Epigenetic instability in ES cells and cloned mice. Science 293:95-97.
57. Jaenisch, R. 1988. Transgenic Animals. Science 240:1468-1474.
58. Jaenisch, R., and I. Wilmut. 2001. Developmental biology. Don't clone humans! Science 291:2552.
59. Jasin, M., M. E. Moynahan, and C. Richardson. 1996. Targeted transgenesis. Proc Natl Acad Sci U S A 93:8804-8808.
60. Jennings, C. 1995. How trinucleotide repeats may function. Nature 378:127.
61. Kahn, P. 1996. Coming to grips with genes and risk. Science 274:496-498.
62. Kay, G. F., G. D. Penny, D. Patel, A. Ashworth, N. Brockdorff, and S. Rastan. 1993. Expression of Xist during mouse development suggests a role in the initiation of X chromosome inactivation. Cell 72:171-182.
63. Keller, G., M. Kennedy, T. Papayannopoulou, and M. V. Wiles. 1993. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 13:473-486.
64. Keller, G. M. 1995. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 7:862-869.
65. Koenig, M., E. P. Hoffman, C. J. Bertelson, A. P. Monaco, C. Feener, and L. M. Kunkel. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509-517.
66. Koopman, P., J. Gubbay, N. Vivian, P. Goodfellow, and R. Lovell-Badge. 1991. Male development of chromosomally female mice transgenic for Sry [see comments]. Nature 351:117-121.
67. Kremer, E. J., M. Pritchard, M. Lynch, S. Yu, K. Holman, E. Baker, S. T. Warren, D. Schlessinger, G. R. Sutherland, and R. I. Richards. 1991. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252:1711-1714.
68. Kunkel, L. M., A. P. Monaco, W. Middlesworth, H. D. Ochs, and S. A. Latt. 1985. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A 82:4778-4782.
69. Lanza, R. P., J. B. Cibelli, C. Blackwell, V. J. Cristofalo, M. K. Francis, G. M. Baerlocher, J. Mak, M. Schertzer, E. A. Chavez, N. Sawyer, P. M. Lansdorp, and M. D. West. 2000. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science 288:665-669.
70. Lewis, J., B. Yang, P. Detloff, and O. Smithies. 1996. Gene modification via "plug and socket" gene targeting. J Clin Invest 97:3-5.
71. Lin, X., C. J. Cummings, and H. Y. Zoghbi. 1999. Expanding our understanding of polyglutamine diseases through mouse models. Neuron 24:499-502.
72. Lobe, C. G., K. E. Koop, W. Kreppner, H. Lomeli, M. Gertsenstein, and A. Nagy. 1999. Z/AP, a double reporter for cre-mediated recombination. Dev. Biology 208:281-292.
73. Lyon, M. F. 1993. Epigenetic inheritance in mammals. Trends Genet. 9:123-128.
74. Makalowski, W., J. Zhang, and M. S. Boguski. 1996. Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. Genome Res 6:846-857.
75. Mangiarini, L., K. Sathasivam, A. Mahal, R. Mott, M. Seller, and G. P. Bates. 1997. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat. Genet. 15:197-200.
76. Mangiarini, L., K. Sathasivam, M. Seller, B. Cozens, A. Harper, C. Hetherington, M. Lawton, Y. Trottier, H. Lehrach, S. W. Davies, and G. P. Bates. 1996. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506.
77. Mann, J. R., I. Gadi, M. L. Harbison, S. J. Abbondanzo, and C. L. Stewart. 1990. Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genetic imprinting. Cell 62:251-260.
78. Mansour, S. L., K. R. Thomas, and M. R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348-352.
79. Marahrens, Y., J. Loring, and R. Jaenisch. 1998. Role of the Xist gene in X chromosome choosing. Cell 92:657-664.
80. Marahrens, Y., B. Panning, J. Dausman, W. Strauss, and R. Jaenisch. 1997. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes & Dev. 11:156-166.
81. McHugh, T. J., K. I. Blum, J. Z. Tsien, S. Tonegawa, and M. A. Wilson. 1996. Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell 87:1339-1349.
82. Megeney, L. A., B. Kablar, K. Garrett, J. E. Anderson, and M. A. Rudnicki. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes & Dev. 10:1173-1183.
83. Meyers, E. N., M. Lewandoski, and G. R. Martin. 1998. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18:136-141.
84. Mills, A. A. 2001. Changing colors in mice: an inducible system that delivers. Genes & Dev. 15:1461-1467.
85. Monaco, A. P., C. J. Bertelson, C. Colletti-Feener, and L. M. Kunkel. 1987. Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet 75:221-227.
86. Monaco, A. P., R. L. Neve, C. Colletti-Feener, C. J. Bertelson, D. M. Kurnit, and L. M. Kunkel. 1986. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323:646-650.
87. Muthusamy, N., K. Barton, and J. M. Leiden. 1995. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377:639-642.
88. Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, I. Nonaka, and Y.-I. Nabeshima. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364:532-535.
89. Nagy, A., and L. Mar. 2001. Creation and use of a Cre recombinase transgenic database. Methods Mol Biol 158:95-106.
90. Norris, D. P., D. Patel, G. F. Kay, G. D. Penny, N. Brockdorff, S. A. Sheardown, and S. Rastan. 1994. Evidence that random and imprinted Xist expression is controlled by preemptive methylation. Cell 77:41-51.
91. Ogonuki, N., K. Inoue, Y. Yamamoto, Y. Noguchi, K. Tanemura, O. Suzuki, H. Nakayama, K. Doi, Y. Ohtomo, M. Satoh, A. Nishida, and A. Ogura. 2002. Early death of mice cloned from somatic cells. Nat. Genet. 30:253-254.
92. Olson, E. N., H. H. Arnold, P. W. Rigby, and B. J. Wold. 1996. Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85:1-4.
93. Perry, A. C., and T. Wakayama. 2002. Untimely ends and new beginnings in mouse cloning. Nat. Genet. 30:243-244.
94. Ramirez-Solis, R., P. Liu, and A. Bradley. 1995. Chromosome engineering in mice. Nature 378:720-724.
95. Rastan, S., and L. J. Beeley. 1997. Functional genomics: going forwards from the databases. Curr. Opin. Genet. Dev. 7:777-783.
96. Reik, W., and J. Walter. 2001. Evolution of imprinting mechanisms: the battle of the sexes begins in the zygote. Nat. Genet. 27:255-256.
97. Reik, W., and J. Walter. 2001. Genomic imprinting: parental influence on the genome. Nat Rev Genet 2:21-32.
98. Richards, R. I., and G. R. Sutherland. 1992. Dynamic mutations: a new class of mutations causing human disease. Cell 70:709-712.
99. Rideout, W. M., 3rd, K. Eggan, and R. Jaenisch. 2001. Nuclear cloning and epigenetic reprogramming of the genome. Science 293:1093-1098.
100. Rideout, W. M., K. Hochedlinger, M. Kyba, G. Q. Daley, and R. Jaenisch. 2002. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109:17-27.
101. Rossant, J. 2002. A monoclonal mouse? Nature 415:967-969.
102. Rowe, L. B., J. H. Nadeau, R. Turner, W. N. Frankel, V. A. Letts, J. T. Eppig, M. S. Ko, S. J. Thurston, and E. H. Birkenmeier. 1994. Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. Mamm Genome 5:253-274.
103. Rozmahel, R., M. Wilschanski, A. Matin, S. Plyte, M. Oliver, W. Auerbach, A. Moore, J. Forstner, P. Durie, J. Nadeau, C. Bear, and L. C. Tsui. 1996. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat. Genet. 12:280-287.
104. Rudnicki, M. A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene myf-5 and results in apparently normal muscle development. Cell 71:383-390.
105. Rudnicki, M. A., P. N. J. Schnegelsberg, R. H. Stead, T. Braun, H.-H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351-1359.
106. Sauer, B. 1998. Inducible gene targeting in mice using the Cre/lox system. Methods 14:381-392.
107. Schmitt, R. M., E. Bruyns, and H. R. Snodgrass. 1991. Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression. Genes & Dev. 5:728-740.
108. Schorpp-Kistner, M., Z. Q. Wang, P. Angel, and E. F. Wagner. 1999. JunB is essential for mammalian placentation. EMBO J. 18:934-948.
109. Shamblott, M. J., J. Axelman, S. Wang, E. M. Bugg, J. W. Littlefield, P. J. Donovan, P. D. Blumenthal, G. R. Huggins, and J. D. Gearhart. 1998. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A 95:13726-13731.
110. Shin, T., D. Kraemer, J. Pryor, L. Liu, J. Rugila, L. Howe, S. Buck, K. Murphy, L. Lyons, and M. Westhusin. 2002. A cat cloned by nuclear transplantation. Nature 415:859.
111. Sibilia, M., and E. F. Wagner. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269:234-238.
112. Silver, L. M. 1995. Mouse Genetics: Concepts and Applications. Oxford University Press, New York.
113. Simpson, E. M., C. C. Linder, E. E. Sargent, M. T. Davisson, L. E. Mobraaten, and J. J. Sharp. 1997. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat. Genet. 16:19-27.
114. Solter, D., and J. Gearhart. 1999. Putting stem cells to work. Science 283:1468-1470.
115. St-Onge, L., P. A. Furth, and P. Gruss. 1996. Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res. 24:3875-3877.
116. Strachan, T., and A. P. Read. 1999. Human Molecular Genetics, 2nd ed. Wiley-Liss, Chichester.
116a.. Stanford, W.L., J.B. Cohn and S.P. Cordes 2001. Gene-trap mutagenesis: past, present and beyond. Nat Rev Genet. 2:756-768.
117. Tajbakhsh, S., E. Bober, C. Babinet, S. Pournin, H. Arnold, and M. Buckingham. 1996. Gene targeting the myf-5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle. Dev. Dynamics 206:291-300.
118. Tajbakhsh, S., and M. E. Buckingham. 1994. Mouse limb muscle is determined in the absence of the earliest myogenic factor myf-5. Proc Natl Acad Sci U S A 91:747-751.
119. Tajbakhsh, S., D. Rocancourt, and M. Buckingham. 1996. Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature 384:266-270.
120. Thomas, K. R., and M. R. Capecchi. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503-512.
121. Thomson, J. A., J. Itskovitz-Eldor, S. S. Shapiro, M. A. Waknitz, J. J. Swiergiel, V. S. Marshall, and J. M. Jones. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
122. Thomson, J. A., and D. Solter. 1988. The developmental fates of androgenetic, parthenogenetic and gynogenetic cells in chimeric gastrulating mouse embryos. Genes & Dev. 2:1344-1351.
123. Tilghman, S. M. 1999. The sins of the fathers and mothers: genomic imprinting in mammalian development. Cell 96:185-193.
124. Tsien, J. Z., D. F. Chen, D. Gerber, C. Tom, E. H. Mercer, D. J. Anderson, M. Mayford, E. R. Kandel, and S. Tonegawa. 1996. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87:1317-1326.
125. Tsien, J. Z., P. T. Huerta, and S. Tonegawa. 1996. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87:1327-1338.
126. Valancius, V., and O. Smithies. 1991. Testing an "in-out" targeting procedure for making subtle genomic modifications in mouse embryonic stem cells. Mol. Cell. Biol. 11:1402-1408.
127. Voss, A. K., T. Thomas, and P. Gruss. 1998. Efficiency assessment of the gene trap approach. Dev. Dynamics 212:171-180.
128. Wakeland, E., L. Morel, K. Achey, M. Yui, and J. Longmate. 1997. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today 18:472-477.
129. Walters, M. C., S. Fiering, J. Eidemiller, W. Magis, M. Groudine, and D. I. Martin. 1995. Enhancers increase the probability but not the level of gene expression. Proc. Natl. Acad. Sci. U.S.A.Proc Natl Acad Sci U S A 92:7125-7129.
130. Walters, M. C., W. Magis, S. Fiering, J. Eidemiller, D. Scalzo, M. Groudine, and D. I. Martin. 1996. Transcriptional enhancers act in cis to suppress position-effect variegation. Genes & Dev. 10:185-195.
131. Wang, Y., P. N. J. Schnegelsberg, J. Dausman, and R. Jaenisch. 1996. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Nature 379:823-825.
132. Wang, Z. Q., F. Kiefer, P. Urbanek, and E. F. Wagner. 1997. Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection. Mech Dev 62:137-145.
133. Weber, B. L., K. J. Abel, L. C. Brody, W. L. Flejter, S. C. Chandrasekharappa, F. J. Couch, S. D. Merajver, and F. S. Collins. 1994. Familial breast cancer. Approaching the isolation of a susceptibility gene. Cancer 74:1013-1020.
134. Wiles, M. V., and G. Keller. 1991. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 111:259-267.
135. Wilmut, I., A. E. Schnieke, J. McWhir, A. J. Kind, and K. H. Campbell. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature 385:810-813.
136. Yamauchi, Y., K. Abe, A. Mantani, Y. Hitoshi, M. Suzuki, F. Osuzu, S. Kuratani, and K. Yamamura. 1999. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev. Biology 212:191-203.
137. Yoon, J. K., E. N. Olson, H. H. Arnold, and B. J. Wold. 1997. Different MRF4 knockout alleles differentially disrupt Myf-5 expression: cis-regulatory interactions at the MRF4/Myf-5 locus. Dev. Biology 188:349-362.
138. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432.
plus
Stem cell characterization
Shi, W., V. Zakhartchenko and E. Wolf 2003. Epigenetic reprogramming in mammalian
nuclear transfer. Differentiation. 71:91-113,
Sapienza, C. 2002. Imprinted gene expression, transplantation medicine, and
the "other" human embryonic stem cell. Proc Natl Acad Sci U S A. 99:10243-10245,
Ramalho-Santos, M., S. Yoon, Y. Matsuzaki, et al. 2002. "Stemness":
transcriptional profiling of embryonic and adult stem cells. Science. 298:597-600,
Ivanova, N.B., J.T. Dimos, C. Schaniel, et al. 2002. A stem cell molecular signature.
Science. 298:601-604.